Hirudin versus citrate as an anticoagulant for ROTEM platelet whole blood impedance aggregometry in thrombocytopenic patients

Hirudin versus citrate as an anticoagulant for ROTEM platelet whole blood impedance aggregometry in thrombocytopenic patients

Citrate is widely used as an anticoagulant for platelet function tests (PFTs). Due to an intrinsic inhibitory effect of citrate on platelet function, hirudin is used as an alternative. However, studies comparing the effect of these anticoagulants on rotational thromboelastometry (ROTEM) platelet who...

Full description

Bibliographic Details
Main Authors:	Wasanthi Wickramasinghe, Bhawani Yasassri Alvitigala, Thisarika Perera, Panduka Karunanayake, Saroj Jayasinghe, Senaka Rajapakse, Praveen Weeratunga, Ananda Wijewickrama, Roopen Arya, Klaus Goerlinger, Lallindra Viranjan Gooneratne
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Platelets
Subjects:	citrate hirudin platelet aggregation thrombocytopenia whole blood impedance aggregometry
Online Access:	http://dx.doi.org/10.1080/09537104.2023.2229909

Similar Items

Rotational thromboelastometry in critical phase of dengue infection: Association with bleeding
by: Wasanthi Wickramasinghe, et al.
Published: (2022-03-01)

Hirudins : antithrombin anticoagulants/
by: 245873 Stringer, Kathleen A., et al.

96-well plate-based aggregometry
by: Melissa V. Chan, et al.
Published: (2018-10-01)

Construction of CDNA library of hirudin and manipulation of polyhedrin promoter for hirudin production /
by: 342760 Normah Norbib
Published: (2004)

The effect of recombinant hirudin on rabbit ear flaps with venous insufficiency
by: Serdar Duzgun, et al.
Published: (2014-01-01)

Hirudin in the Treatment of Chronic Kidney Disease
by: Sai-Ji Liu, et al.
Published: (2024-02-01)

Structural Analysis of Hirudin Using FT-IR and FT-Raman Spectroscopic Techniques
by: Amanollah Aminzadeh
Published: (2000-11-01)

How to perform aggregometry and lumi-aggregometry in mouse platelets
by: Craig E. Hughes
Published: (2018-10-01)

Platelet-covered nanocarriers for targeted delivery of hirudin to eliminate thrombotic complication in tumor therapy
by: Zhang, Kai, et al.
Published: (2023)

In silico designing of a new cysteine analogue of hirudin variant 3 for site specific PEGylation
by: Seyed Mehdi Sajjadi, et al.
Published: (2017-01-01)

Hirudin ameliorates immunoglobulin A nephropathy by inhibition of fibrosis and inflammatory response
by: Fei Deng, et al.
Published: (2019-01-01)

The use of rotational thromboelastometry parameters in understanding the coagulopathy following hump-nosed viper (Hypnale spp) bites: a preliminary study
by: Bhawani Yasassri Alvitigala, et al.
Published: (2023-01-01)

Network Pharmacology and In Vitro Experimental Verification Reveal the Mechanism of the Hirudin in Suppressing Myocardial Hypertrophy
by: Mengnan Liu, et al.
Published: (2022-06-01)

Platelet function testing in cardiac surgery: A comparative study of electrical impedance aggregometry and thromboelastography
by: Bilal H. Kirmani, et al.
Published: (2017-08-01)

Advances in Platelet Function Testing—Light Transmission Aggregometry and Beyond
by: Jessica Le Blanc, et al.
Published: (2020-08-01)

The Effect of Signal Sequence and His-tags on the Expression and Anti-Thrombin Activity of Recombinant Hirudin
by: Shahin Hadadian, et al.
Published: (2021-06-01)

The Effect of Hirudin Herbal-acupuncture on Neurotransmitters against Middle Cerebral Artery Occulsion(MCAO) Rats
by: Suk Jae-Wook, et al.
Published: (2004-06-01)

Identification and characterization of hirudin-HN, a new thrombin inhibitor, from the salivary glands of Hirudo nipponia
by: Boxing Cheng, et al.
Published: (2019-09-01)

Hirudin Protects Against Kidney Damage in Streptozotocin-Induced Diabetic Nephropathy Rats by Inhibiting Inflammation via P38 MAPK/NF-κB Pathway
by: Han J, et al.
Published: (2020-08-01)

Whole blood platelet aggregation determined by the ROTEM platelet equipment; reference intervals and stability
by: Peter H. Nissen, et al.
Published: (2020-02-01)

Design and fabrication of r-hirudin loaded dissolving microneedle patch for minimally invasive and long-term treatment of thromboembolic disease
by: Mengfang Wu, et al.
Published: (2022-03-01)

Optimized tool for evaluation of platelet function measured by impedance aggregometry
by: Anna Schultz-Lebahn, et al.
Published: (2021-08-01)

Preparation of Hirudin-Loaded Chitosan/Polycaprolactone Bowl-Shaped Particles and an Application for a Drug Delivery System
by: Xiang Li, et al.
Published: (2024-02-01)

Is there an ideal way to initiate antiplatelet therapy with aspirin? A crossover study on healthy volunteers evaluating different dosing schemes with whole blood aggregometry
by: Overbeck Ursula, et al.
Published: (2011-04-01)

Assessment of light transmission aggregometry on the routine coagulation analyzer Sysmex CS-2500 using CE-marked agonists from Hyphen Biomed
by: V.-E. Bret, et al.
Published: (2019-05-01)

Automated Light Transmission Aggregometry with and without Platelet Poor Plasma Reference: A Method Comparison
by: Ulrich J. Sachs, et al.
Published: (2023-01-01)

Harmonizing light transmission aggregometry in the Netherlands by implementation of the SSC-ISTH guideline
by: I.C.A. Munnix, et al.
Published: (2021-05-01)

Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy
by: Bhawani Yasassri Alvitigala, et al.
Published: (2020-12-01)

Aggregometry and thromboelastography to identify the timing to trach a COVID‐19 patient receiving both antiplatelet therapy and enoxaparin
by: Marco Tescione, et al.
Published: (2021-03-01)

Point-of-care HEMOstasis in children with congenital heart disease, the POCHEMO study: Rotational thromboelastometry and impedance aggregometry in children with cyanotic and non-cyanotic congenital heart disease
by: Marie-Hélène Perez, et al.
Published: (2022-06-01)

Platelet aggregometry interpretation using ROTEM – PART – II
by: Vandana Bhardwaj, et al.
Published: (2016-01-01)

Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry
by: Hamzah Khan, et al.
Published: (2020-10-01)

Effects of Time-Interval since Blood Draw and of Anticoagulation on Platelet Testing (Count, Indices and Impedance Aggregometry): A Systematic Study with Blood from Healthy Volunteers
by: Michael Hardy, et al.
Published: (2020-08-01)

TEG Platelet Mapping and Impedance Aggregometry to Predict Platelet Transfusion During Cardiopulmonary Bypass in Pediatric Patients
by: Erin E. Barker, et al.
Published: (2019-12-01)

Hirudin inhibit the formation of NLRP3 inflammasome in cardiomyocytes via suppressing oxidative stress and activating mitophagy
by: Gang Luo, et al.
Published: (2024-01-01)

A case of repetitive intraoperative use of recombinant hirudin (Lepirudin) for peripheral vascular surgery heparin induced thrombocytopenia and thrombosis (HITT) - evidence for a decrease in platelet consumption in the absence of active thrombosis
by: F Goti, et al.
Published: (2001-12-01)

Recombinant hirudin attenuates pulmonary hypertension and thrombosis in acute pulmonary embolism rat model
by: Xiang Wei, et al.
Published: (2024-04-01)

Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: Diona Gjermeni, et al.
Published: (2022-07-01)

Transcriptome-Based Network Analysis Reveals Hirudin Potentiates Anti-Renal Fibrosis Efficacy in UUO Rats
by: Hang-Xing Yu, et al.
Published: (2021-09-01)

The use of regression analysis in determining reference intervals for low hematocrit and thrombocyte count in multiple electrode aggregometry and platelet function analyzer 100 testing of platelet function
by: Gerhardus J. A. J. M. Kuiper, et al.
Published: (2017-10-01)